Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Anemia, Iron-Deficiency

• Comparison of Twice Weekly Versus Daily Iron Therapy in Treating Anemia in Children With Cerebral Palsy
• Effect of Iron and Vitamin D Supplementation to Iron Status in Iron Deficiency Anemia
• Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia
• Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia
• The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life
• Iron Deficiency Anemia (IDA)
• A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia).
• Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure
• Analysis of the Effect of Iron Supplements on Iron Deficiency Anemia in Pregnancy
• The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)
• Impact of Intravenous Iron on Musculoskeletal Function in Older Adults
• Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency
• ORal IrON Supplementation With Ferric Maltol in Treating Iron Deficiency and Anaemia in Patients With Heart Failure (ORION-HF)
• Prevention of Iron Deficiency Anemia Post-delivery
• Oral Iron Supplementation for Patients With Chronic Kidney Disease
• Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS
• Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
• Predicting Response to Iron Supplementation in Patients With Inflammatory Bowel Disease During Induction Therapy
• Treatment of Non-Anemic Iron Deficiency in Pregnancy
• Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
• Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial
• Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
• An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function
• IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department
• The Efficacy of Intermittent Versus Daily Oral Iron Supplementation in Anaemic Pregnant Women.
• Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy
• Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis
• Effects of Preoperative Correction of Anemia With Intravenously Iron in Colorectal Cancer Patients.
• Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer
• Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia
• Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years
• Treatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy
• Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia
• Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
• Nutrition Intervention to Address Anemia Among Adolescent Girls in Liberia
• Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia
• Alternate Day Versus Daily Oral Iron Therapy in Adolescents
• Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON)
• Iron Deficiency Anemia in Twin Pregnancies
• Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia
• Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)
• Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants
• Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients
• Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass Grafting
• The Iron and Muscle Study
• Iron Sucrose in Patients With Iron Deficiency and POTS
• IV Sodium Ferric Gluconate Complex in Patients Undergoing TAVI
• Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency
• Iron Supplementation and Neurodevelopmental Outcome in ELGANs
• Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
• Do Iron And Vitamin B12 Injections Given Together, Improve Hemoglobin In Patients On Hemodialysis?
• Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers
• Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery
• Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in Pregnancy
• Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic Trial
• Iron Deficiency as an Ignored Cause of Infertility
• Intravenous Versus Oral Iron Therapy in Hemodialysis Patients
• Lactoferrin for Treatment of Iron Deficiency Anemia.
• Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD)
• Effect of Ultra-short-term Treatment of Patients With Iron Deficiency or Anemia Undergoing Adolescent Scoliosis Correction
• Lactoferrin in Treatment of Fe Deficient Anemia In Cirrhosis
• Neurovascular Complications and White Matter Damage in Acquired Anemias
• Assessment of the eFficacy, the Onset-of-Action and the Safety of Tot'héma® in Adults With Moderate Iron Deficiency Anaemia
• Early Antenatal Support for Iron Deficiency Anemia
• Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044
• Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
• Lactoferrin Efficacy Versus Ferrous Sulfate in Treatment of Patients With Iron Deficiency Anemia
• Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia
• Evaluation on Performance and Oxydative Stress in Patient With Iron deficIency and Stable Heart Failure Study
• Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis
• IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding
• Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer
• Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia
• The Oral Iron on the Prevention of Iron Deficiency Anemia in Obese Pregnant
• Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in Patients
• Hepcidin and Glucose Metabolism
• Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Mod
• Iron in Patients With Cardiovascular Disease
• Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia
• Lactoferrin Versus Ferrous Sulfate in Management of Iron Deficiency Anemia Among Female Medical Ain Shams Students
• Short-term Intravenous Iron Dextran for IDA
• A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
• Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE)
• ProPBM : A Modified Patient Blood Management Protocol
• Doubling the Iron Dose to Prevent IDA in Twin Pregnant Women
• Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF)
• Amino Acid Chelated Iron Versus Ferrous Fumarate in the Treatment of Iron Deficiency Anemia With Pregnancy: Randomized Controlled Trial
• Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency
• Effects of Iron Therapy and Exercise Training in Patients With Heart Failure and Iron Deficiency
• Intravenous (IV) Versus Oral Iron Treatment of Iron Deficiency Anemia in the Post-operative Bariatric Surgical Patient
• ORal IrON Supplementation With Ferric Maltol in Patients With Heart Failure Carrying Left Ventricular Assist Devices
• Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation
• Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery
• Lactoferrin Versus Ferrous Sulfate in Iron-deficiency During Pregnancy
• the Effectiveness of Lactoferrin in Treatment of Iron Deficiency Anemia in Children With Chronic Tonsillitis
• Daily vs. Every Other Day Oral Iron Supplementation in Patients With Absolute Iron Deficiency Anemia
• Iron Status and Cardiopulmonary Physiology
• Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients
• Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy
• Intravenous Iron in Adults With Cystic Fibrosis
• Impact and Evaluation of the Management of Iron Deficiency With or Without Anemia in Patients With Cancer
• A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
• Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients
• To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia
• Efficacy of Preoperative Intravenous Iron in Anaemic Colorectal Cancer Surgical Patients
• Oral Lactoferrin Versus Iron Supplementation During Pregnancy
• Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia
• Ferrous Acetyl-Aspartate Casein Formulation Evaluation Over Ferrous Sulfate in Iron Deficiency Anemia
• Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA
• A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia
• Lactoferrin Versus Ferrous Fumarate for Treatment of Mild to Moderate Iron Deficiency Anemia During Pregnancy
• A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease
• Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial
• A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia
• Changes in Myocardial Iron After Iron Administration
• Efficacy of Iron Bisglycinate in Treatment of Iron Deficiency Anemia in Pregnant Women
• ORal IrON Supplementation With Ferric Maltol in Patients With Pulmonary Hypertension (ORION-PH-1)
• Iron Deficiency Anemia, Iron Supplementation and Genomic Stability in Infants
• Eradication of H-pylori in Pregnancy and Its Effect on Iron Replacement Therapy?
• Evaluating Iron Protein Succinylate Oral Solution in Treating Chronic Heart Failure and Iron Deficiency
• Effect of Iron on Cerebral Dopamine Receptor Density in Non-anaemic Premenopausal Women With Low Ferritin and Fatigue
• A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients.
• Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
• Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
• KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
• Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia
• Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency
• Bovine Lactoferrin Versus Ferrous Sulphate In The Treatment Of Iron Deficiency Anemia During Pregnancy
• Effectiveness of Adaptation of the Dose of Iron Supplementation in Pregnancy on Maternal-child Health. (ECLIPSES)
• A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.
• Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.
• Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency
• to Assess the Effect of Early vs Routine Iron Supplementation on Iron Store and Growth in Term Infants
• FLIPS: Ferfer Liposomal Iron Performance Study
• Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency
• Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction
• Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease
• Treatment With IV Iron in Hospitalized Patients With Severe Heart Failure But Without Iron Deficiency
• Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
• Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality
• Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)
• Iron Sucrose Versus Ferrous Bis-glycinate for Treatment of Iron Deficiency Anemia
• Short Term Oral Iron Supplementation in Systolic Heart Failure Patients Suffering From Iron Deficiency Anemia
• The Safety of a High-Dose, Rapid Infusion of Iron Sucrose
• Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
• An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®)
• Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy
• Effects of a Dietary Approach to Iron Deficiency in Premenopausal Women Affected by Celiac Disease
• Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)
• Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease
• Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency
• Sucrosomial Iron in Patients With Celiac Disease and IDA
• Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol
• A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer
• Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality
• Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
• Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia
• Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia
• Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With IBD
• Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers
• Efficacy Study of Intravenous Iron Preparation to Iron Deficiency Anemia
• A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)
• Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
• Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN
• the Efficacy and Safety of Vitamin C for Iron Supplementation in Adult IDA Patients
• Maintenance of Multivitamin Supplements After Sleeve Gastrectomy
• The Effect of Iron Deficiency Anemia During Pregnancy
• A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients
• Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With The Intravenous Iron (Monofer®)
• IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
• Ferrous Sulphate Supplement (V0355) in Women With Iron Deficiency Anaemia
• Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)
• Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D
• Different Iron Supplements for Prevention of Anemia in Pregnancy
• Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.
• A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA
• Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia
• Hospitalization & Mortality in Patients With Iron Deficiency CKD and HF Treated With i.v. Iron.
• Iron Status and Human Metabolism
• A Non-interventional Study of Diafer in Subjects With CKD on Haemodialysis for Treatment of Iron Deficiency
• Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass
• Supplementing Iron and Development in Breastfed Infants (SIDBI Study)
• Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)
• Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency
• Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery
• A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo
• Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency Anemia
• IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose
• A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia
• Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass
• Iron Supplementation Using Total Dose Infusion and Oral Routes for Treatment of Iron Deficiency Anemia in Pregnancy
• Comparison of Ferrous Sulfate, Polymaltose Complex and Iron-zinc in Iron Deficiency Anemia
• RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone
• Impact of Preoperative Treatment of Anemia and Iron Deficiency in Cardiac Surgery on Outcome.
• Randomized Study Comparing Ferric Carboxymaltose to Iron Sucrose to Treat Fe Deficiency in the Surgically Critically Ill
• Treatment of Iron Deficiency Anemia With Pregnancy
• Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate
• Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS)
• Differential Gene Expression in Patients With Heart Failure and Iron Deficiency - Effects of Ferric Carboxymaltose
• Trial to Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron and to Compare Safety, Effect on Quality of Life, and Resource Utilization of Injectafer vs Intravenous Standard of Care for the Treatment of IDA in an Inf
• Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients
• Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
• Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
• Iron Deficiency and Hereditary Haemorrhagic Telangiectasia
• Comparison of NovaFerrum® vs Ferrous Sulfate Treatment in Young Children With Nutritional Iron Deficiency Anemia
• Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer®)
• A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Iron-deficient Blood Donors
• The Benefits of a Preoperative Anemia Management Program
• A Pilot Study Comparing Tolerance of Oral Heme Iron Polypeptide With Oral Ionic Iron
• Endovenous Versus Liposomal Iron in CKD
• Iron Supplementation for Acute Anemia After Postbariatric Abdominoplasty
• Iron Status and Hypoxic Pulmonary Vascular Responses
• Iron in Congestive Heart Failure
• Oxidative Stress and Inflammation Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency Anemia
• Intravenous High Dose Iron in Blood Donors
• Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia
• Does a Daily Iron Tablet Improve Anemia in Cystic Fibrosis
• Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
• Enhancing Treatment of Iron Deficiency and Iron Deficiency Anemia With an Antioxidant, Vitamin E
• Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency
• Iron Repletion in Chronic Cough and Iron Deficiency
• A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency
• IV Iron Replacement for Iron Deficiency in Idiopathic Pulmonary Arterial Hypertension (IPAH) Patients
• IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD
• A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized Trial to Evaluate Efficacy & Safety in Anemia Subjects
• Hibiscus Sabdariffa and Centella Asiatica in the Treatment of Anemia by Iron Deficiency
• Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure
• Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia
• Effect Of Intravenous Iron Versus Placebo On Muscle Oxidative Capacity And Physical Performance in Premenopausal Women
• Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)
• Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)
• Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding
• Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women
• A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
• Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy
• Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis
• Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated Pregnancies
• A Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficiency Anaemia and to Compare These With Those of Ferrous Ascorbate.
• A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease
• A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
• Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)
• Iron Indices and Intravenous Ferumoxytol: Time to Steady State
• Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
• Directly Observed Iron Supplementation to Treat Anemia
• A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia
• A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia
• A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia
• Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age
• Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia
• Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy
• Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy
• A Trial of Iron Replacement in Patients With Iron Deficiency.
• A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease
• Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia
• Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
• Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
• Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function
• Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia
• Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
• A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease
• EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure
• FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR
• Maintenance Treatment of Iron Deficiency in IBD Patients
• Efficacy and Safety Study of Iron Sucrose and Oral Iron Acetyl-transferrin Hydroglycerin
• Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment
• Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia
• Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery
• Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia
• Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia
• Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia
• Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors
• Iron-Deficiency Anemia in Infants in Two Weekly Programs
• Trial Comparing the Safety of Two Different Intravenous Iron Formulations
• Iron Supplementation of Marginally Low Birth Weight Infants
• Interest of Biofer ® Compound Used in Blédilait Follow on Milk in Infant With Latent Iron Deficiency
• Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients
• Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients
• A Study of Iron Oligosaccharide in Chronic Kidney Disease Patients
• Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism
• Comparison Between Effects of Two Iron Preparations on Protein in the Urine
• Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)
• Prevention of Iron Deficiency in 2nd Year of Life
• Helicobacter Pylori and Iron Deficiency: Prevalence of Association and Effect of Therapy
• Relative Bioavailability of Ferric Pyrophosphate From an Apple Juice Drink
• Effect of Coca-Cola on Iron Absorption
• Early Versus Late Enteral Iron in Infants Less Than 1301 Grams
• Neurodevelopment After Early Iron Supplementation
• Malabsorption as a Cause of Iron Treatment Failure in Infants
• Assessment of Anaemia Attributable to Schistosomiasis in School Children in Kenya: Mechanisms and Effect of Treatment
• A Test of Iron Malabsorption in Patients With Iron Deficiency Anemia
• Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children
• Effect of Two Iron Preparations on Protein in the Urine
• Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure
• Efficacy of Intravenous Iron Administration in Hemodialysis Patients
• Is Helicobacter Pylori Infection a Cause or Treatment Failure of Iron Deficiency Anemia in Children in Bangladesh?
• Treatment of Anemia in the 2nd Year of Life. Comparison of the Efficacy of Two Different Iron Preparations.
• DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
• Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients
• Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents
• 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.
• Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients
• Using Iron Supplementation to Decrease Iron Deficiency Anemia in Infants and Young Children in India
• The Effect of H. Pylori Infection on Iron Metabolism
• Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.
• Iron Supplementation Among Adolescent Girls in India
• Adherence With Iron Sprinkles Among High-Risk Infants
• Effect of Intravenous Ferrous Sucrose on Exercise Capacity in Chronic Heart Failure